Market Monitor chemicals Italy 2019

Αποδόσεις Κλάδου

  • Ιταλία
  • Χημικά / Φαρμακοβιομηχανία

16 Ιουλ 2019

Performance is affected by slowdown in demand from automotive, uncertainty about Italian fiscal policy and the trade dispute between the US and China.


  • Sluggish growth due to lower demand from key buyer industries
  • Payments take 60 days on average
  • Insolvencies expected to increase in 2019





2019 italy chem 1








Italian chemicals production increased only 1% in 2018, as exports (accounting for 55% of total revenues) grew 2%, compared to 9% in 2017. Domestic demand even contracted in Q4 of 2018. Demand from key buyer sectors, such as the domestic construction industry and the European automotive industry slowed down last year. Chemicals sales to automotive decreased further in H1 of 2019, and there is no rebound in sight.






2019 italy chem 2





Due to the sluggish growth of the Italian economy, domestic demand for chemicals is expected to increase a meagre 0.9% in 2019, while exports are forecast to increase 1.9%. Overall production growth will rise 0.7%. Besides the global slowdown in demand from automotive, the sector’s performance is affected by uncertainty about Italian fiscal policy and the trade dispute between the US and China, as well as simmering trade tensions between the US and the EU.



Production of the pharmaceuticals industry in Italy amounted to EUR 32 billion in 2018 (up 3% year-on-year), with Italian-owned producers accounting for 40% of total revenues. Exports accounted for 79% of total revenues, while expenditure for pharmaceuticals in Italy is among the lowest in Europe, and decreasing further.



2019 italy chem 3



Despite the more difficult market environment, profit margins of Italian chemicals/pharmaceuticals businesses are expected to remain generally stable over the coming 12 months. On average, payments in the Italian chemicals/pharmaceuticals sector take around 60 days. Payment experience is average, and the level of protracted payments has been stable over the past couple of years.


While the number of insolvencies in the chemicals sector is the lowest of all Italian industries, we expect a (small) increase in payment delays and business failures over the coming 6 months, triggered by lower demand from all main customer segments and long days sales outstanding (DSO) when delivering to end markets. Access to bank loans could tighten after the European Central Bank´s Quantitative Easing programme ends. However, we expect that the insolvency increase in the chemicals sector will remain below the 6% rise we forecast for all Italian business insolvencies in 2019.


2019 italy chem 4


Considering the still low level of bank bad debt and the above-average solvency of many businesses, our underwriting approach to the Italian chemicals/pharmaceuticals sector remains positive to neutral.

Nevertheless, our approach is restrictive for the petrochemicals segment, which is impacted by price volatility and fierce competition, combined with a weak financial structure of many businesses. Especially petrochemicals wholesalers show very low margins, with low prices and fiscal crimes being an issue. Pharmaceuticals wholesalers generally have low solvency and high gearing ratios. Bank support is crucial for working capital requirements due to long DSO from end customers.






Σχετικά έγγραφα

Αποποίηση ευθυνών

Οι δηλώσεις που γίνονται στο παρόν παρέχονται αποκλειστικά για γενικούς ενημερωτικούς σκοπούς και δεν πρέπει να γίνεται επίκληση για οποιονδήποτε σκοπό . Ανατρέξτε για τους ισχύοντες όρους στο σώμα του Ασφαλιστηρίου Συμβολαίου ή στο σχετικό συμφωνητικό προϊόντος ή υπηρεσίας. Τίποτα στο παρόν δεν πρέπει να εκληφθεί ότι δημιουργεί κανένα δικαίωμα, υποχρέωση, σύσταση ή ευθύνη εκ μέρους της Atradius , συμπεριλαμβανομένης οποιασδήποτε υποχρέωσης για τη διεξαγωγή due diligence επί των αγοραστών ή για λογαριασμό σας . Αν η Atradius διεξάγει due diligence σε οιονδήποτε αγοραστή, αυτό γίνεται για δικούς της σκοπούς σχετικά με την αξιολόγηση του κινδύνου και όχι προς όφελος του ασφαλισμένου ή οποιουδήποτε άλλου προσώπου . Επιπλέον , σε καμία περίπτωση η Atradius και οι συνδεδεμένες και θυγατρικές εταιρείες μπορούν να καταστούν υπεύθυνες για οποιεσδήποτε άμεσες , έμμεσες , ειδικές, τυχαίες ή αποθετικές ζημίες που απορρέουν από τη χρήση δηλώσεων ή πληροφοριών στο παρόν .